• Fri, January 6, 2023
Puneet Souda Maintained (ABCL) at Buy with Decreased Target to $18 on, Jan 6th, 2023
Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $20 to $18 on, Jan 6th, 2023.
Puneet has made no other calls on ABCL in the last 4 months.
There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Puneet
- Andrea Tan of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Thursday, December 15th, 2022
- Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $29 on, Wednesday, November 16th, 2022
Like: 👍
